These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

114 related items for PubMed ID: 17495861

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Renal L-type fatty acid-binding protein mediates the bezafibrate reduction of cisplatin-induced acute kidney injury.
    Negishi K, Noiri E, Maeda R, Portilla D, Sugaya T, Fujita T.
    Kidney Int; 2008 Jun; 73(12):1374-84. PubMed ID: 18368030
    [Abstract] [Full Text] [Related]

  • 3. Fibrate prevents cisplatin-induced proximal tubule cell death.
    Nagothu KK, Bhatt R, Kaushal GP, Portilla D.
    Kidney Int; 2005 Dec; 68(6):2680-93. PubMed ID: 16316343
    [Abstract] [Full Text] [Related]

  • 4. Metabolomic study of cisplatin-induced nephrotoxicity.
    Portilla D, Li S, Nagothu KK, Megyesi J, Kaissling B, Schnackenberg L, Safirstein RL, Beger RD.
    Kidney Int; 2006 Jun; 69(12):2194-204. PubMed ID: 16672910
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Reduced kidney lipoprotein lipase and renal tubule triglyceride accumulation in cisplatin-mediated acute kidney injury.
    Li S, Nagothu K, Ranganathan G, Ali SM, Shank B, Gokden N, Ayyadevara S, Megyesi J, Olivecrona G, Chugh SS, Kersten S, Portilla D.
    Am J Physiol Renal Physiol; 2012 Aug 01; 303(3):F437-48. PubMed ID: 22622461
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Renal liver-type fatty acid binding protein (L-FABP) attenuates acute kidney injury in aristolochic acid nephrotoxicity.
    Matsui K, Kamijo-Ikemorif A, Sugaya T, Yasuda T, Kimura K.
    Am J Pathol; 2011 Mar 01; 178(3):1021-32. PubMed ID: 21356355
    [Abstract] [Full Text] [Related]

  • 10. Amelioration of diabetic tubulointerstitial damage in liver-type fatty acid-binding protein transgenic mice.
    Kamijo-Ikemori A, Sugaya T, Sekizuka A, Hirata K, Kimura K.
    Nephrol Dial Transplant; 2009 Mar 01; 24(3):788-800. PubMed ID: 18854419
    [Abstract] [Full Text] [Related]

  • 11. Interstitial renal fibrosis due to multiple cisplatin treatments is ameliorated by semicarbazide-sensitive amine oxidase inhibition.
    Katagiri D, Hamasaki Y, Doi K, Negishi K, Sugaya T, Nangaku M, Noiri E.
    Kidney Int; 2016 Feb 01; 89(2):374-85. PubMed ID: 26535996
    [Abstract] [Full Text] [Related]

  • 12. Liver-type fatty acid-binding protein attenuates renal injury induced by unilateral ureteral obstruction.
    Kamijo-Ikemori A, Sugaya T, Obama A, Hiroi J, Miura H, Watanabe M, Kumai T, Ohtani-Kaneko R, Hirata K, Kimura K.
    Am J Pathol; 2006 Oct 01; 169(4):1107-17. PubMed ID: 17003471
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Anti-inflammatory effect of fibrate protects from cisplatin-induced ARF.
    Li S, Gokden N, Okusa MD, Bhatt R, Portilla D.
    Am J Physiol Renal Physiol; 2005 Aug 01; 289(2):F469-80. PubMed ID: 15814532
    [Abstract] [Full Text] [Related]

  • 16. [Urinary L-type fatty acid binding protein (L-FABP) as a new urinary biomarker promulgated by the Ministry of Health, Labour and Welfare in Japan].
    Kamijo-Ikemori A, Ichikawa D, Matsui K, Yokoyama T, Sugaya T, Kimura K.
    Rinsho Byori; 2013 Jul 01; 61(7):635-40. PubMed ID: 24205707
    [Abstract] [Full Text] [Related]

  • 17. Variation of liver-type fatty acid binding protein content in the human hepatoma cell line HepG2 by peroxisome proliferators and antisense RNA affects the rate of fatty acid uptake.
    Wolfrum C, Buhlmann C, Rolf B, Börchers T, Spener F.
    Biochim Biophys Acta; 1999 Feb 25; 1437(2):194-201. PubMed ID: 10064902
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.